In this study, we used a combination of bioinformatics and experimental validation methods to systematically evaluate the expression of ADGRG2 in HCC, as well as its correlation with diagnosis, prognosis, cancer occurrence and development, immune infiltration, and inflammation. This evidence concerns the gene ADGRG2 and hepatocellular carcinoma.